Back to Amundi Amundi

KNSAKNSA

5 quarters

Position history for AmundiAmundi's holdings in Kiniksa Pharmaceuticals International, plc

No. Amundi exited its KNSA (Kiniksa Pharmaceuticals International) position in Q1 2026. Its Q4 2025 13F listed 23,496 shares worth $969,210. Amundi first reported KNSA in Q1 2025 and held it in 3 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$347,551

Total Shares Change

-15,972

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q1
Latest
Exited
0
-100.0%
$00.0%$48.15
0
2025-Q4
New
23,496
—
$969,2100.0%$41.25
35
2025-Q3
Exited
0
-100.0%
$00.0%$38.83
0
2025-Q2
Unchanged
15,972
0.0%
$438,2720.0%$27.67
0
2025-Q1
New
15,972
—
$347,5510.0%$22.21
33

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used